
  
    
      
        
        Last_JJ year_NN the_DT European_NNP Parliament_NNP and_CC Council_NNP formed_VBD the_DT european_NN and_CC Developing_VBG
        Countries_NNPS Clinical_NNP Trials_NNP Partnership_NNP (_( EDCTP_NNP )_) ._. The_DT aim_NN of_IN this_DT new_JJ funding_NN body_NN ,_, which_WDT has_VBZ
        a_DT budget_NN of_IN &_CC euro_NN ;_: 400_CD million_CD spread_NN over_IN five_CD years_NNS ,_, is_VBZ a_DT noble_JJ one_CD :_: to_TO fund_VB research_NN
        in_IN developing_VBG countries_NNS ,_, particularly_RB in_IN Africa_NNP ,_, that_WDT contributes_VBZ to_TO the_DT development_NN of_IN
        affordable_JJ prophylactics_NNS and_CC drugs_NNS for_IN HIV_NNP /_NN AIDS_NNP ,_, tuberculosis_NNS ,_, and_CC malaria_NN ._.
        Unfortunately_RB ,_, the_DT organization_NN has_VBZ not_RB got_VBN off_RP to_TO an_DT auspicious_JJ start_NN ._. Its_PRP$ executive_NN
        director_NN ,_, Piero_NNP Olliaro_NNP ,_, was_VBD ousted_VBN from_IN power_NN at_IN the_DT first_JJ EDCTP_NNP annual_JJ forum_NN at_IN the_DT end_NN
        of_IN September_NNP ._. There_EX have_VBP been_VBN rumblings_NNS of_IN discontent_NN among_IN grant_NN applicants_NNS who_WP say_VBP that_IN
        the_DT first_JJ round_NN of_IN grant_NN assessments_NNS was_VBD administered_VBN poorly_RB ._. And_CC not-for-profit_JJ
        organizations_NNS that_WDT would_MD like_VB to_TO partner_NN with_IN EDCTP_NNP have_VBP been_VBN left_VBN in_IN the_DT dark_JJ regarding_VBG
        whom_WP to_TO speak_VB to_TO at_IN the_DT organization_NN ._.
        This_DT omission_NN is_VBZ significant_JJ because_IN partnership_NN is_VBZ one_CD of_IN the_DT key_JJ tenets_NNS of_IN the_DT EDCTP_NNP ._.
        European_JJ research_NN agencies_NNS are_VBP slowly_RB beginning_VBG to_TO realize_VB that_IN they_PRP need_VBP to_TO cooperate_VB with_IN
        each_DT other_JJ if_IN they_PRP are_VBP to_TO be_VB competitive_JJ with_IN the_DT United_NNP States_NNPS ._. The_DT history_NN of_IN many_JJ
        European_JJ countries_NNS is_VBZ such_JJ that_IN Europe_NNP has_VBZ much_RB stronger_JJR ties_NNS with_IN Africa_NNP than_IN does_VBZ the_DT
        United_NNP States_NNPS ,_, so_IN it_PRP makes_VBZ political_JJ sense_NN for_IN the_DT European_NNP Union_NNP to_TO fund_VB research_NN that_WDT
        provides_VBZ a_DT springboard_NN for_IN European_JJ researchers_NNS to_TO compete_VB effectively_RB with_IN US_NNP
        scientists_NNS ._.
        Crucially_NNP ,_, the_DT EDCTP_NNP was_VBD also_RB set_VBN up_RP to_TO enable_VB European_JJ and_CC African_JJ scientists_NNS to_TO work_VB
        together_RB as_IN equal_JJ partners_NNS ._. There_EX is_VBZ increasing_VBG recognition_NN that_IN the_DT paternalistic_JJ ,_,
        colonial_NN attitude_NN that_WDT pervaded_VBD “ tropical_JJ medicine_NN” in_IN the_DT past_NN just_RB will_MD not_RB do_VB ._. The_DT EDCTP_NNP
        hoped_VBD to_TO change_VB that_IN by_IN having_VBG a_DT Partnership_NNP Board_NNP that_WDT contains_VBZ equal_JJ numbers_NNS of_IN African_JJ
        and_CC European_JJ representatives_NNS ._. However_RB ,_, the_DT EDCTP_NNP Assembly_NNP ,_, which_WDT contains_VBZ a_DT representative_NN
        from_IN each_DT of_IN 14_CD EU_NNP member_NN states_NNS but_CC none_NN from_IN African_JJ countries_NNS ,_, has_VBZ the_DT power_NN to_TO veto_VB the_DT
        decisions_NNS of_IN the_DT Partnership_NNP Board_NNP ,_, which_WDT is_VBZ supposedly_RB the_DT scientific_JJ decision-making_NN
        authority_NN ._.
        Doing_VBG clinical_JJ trials_NNS in_IN Africa_NNP is_VBZ far_RB from_IN easy_JJ ._. There_EX are_VBP too_RB few_JJ adequately_RB resourced_JJ
        research_NN centers_NNS ,_, and_CC those_DT that_WDT do_VBP consistently_RB perform_VB well_RB are_VBP oversubscribed_VBN ._.
        Therefore_RB ,_, there_EX is_VBZ a_DT clear_JJ need_NN for_IN "_'' capacity_NN building_NN "_'' —_NN development_NN of_IN a_DT research_NN
        infrastructure_NN ,_, in_IN terms_NNS of_IN both_DT equipment_NN and_CC personnel_NNS ,_, that_WDT is_VBZ capable_JJ of_IN coping_VBG with_IN
        the_DT challenges_NNS of_IN clinical_JJ trials_NNS ._. The_DT EDCTP_NNP hopes_VBZ to_TO contribute_VB to_TO this_DT essential_JJ endeavor_NN
        by_IN funding_VBG clinical_JJ trials_NNS that_WDT are_VBP sustainable_JJ in_IN the_DT long_JJ term_NN ._. In_IN particular_JJ ,_, it_PRP
        believes_VBZ that_IN the_DT best_JJS way_NN to_TO train_VB a_DT new_JJ generation_NN of_IN African_JJ scientists_NNS is_VBZ by_IN teaching_VBG
        them_PRP on_IN the_DT job_NN ,_, that_WDT is_VBZ ,_, involving_VBG them_PRP fully_RB in_IN the_DT planning_NN and_CC execution_NN of_IN the_DT trial_NN ,_,
        rather_RB than_IN flying_VBG in_IN European_JJ experts_NNS who_WP leave_VBP as_RB soon_RB as_IN the_DT trial_NN is_VBZ finished_VBN ._.
        A_DT commitment_NN from_IN European_JJ researchers_NNS to_TO be_VB engaged_VBN for_IN the_DT long_JJ term_NN is_VBZ essential_JJ for_IN
        the_DT success_NN of_IN these_DT projects_NNS ._. In_IN addition_NN ,_, partnerships_NNS need_VBP to_TO be_VB brokered_JJ with_IN national_JJ
        programs_NNS in_IN Africa_NNP to_TO ensure_VB that_IN the_DT new_JJ capacity_NN can_MD be_VB sustained_VBN over_IN time_NN ._. The_DT end_NN goal_NN
        is_VBZ to_TO produce_VB centers_NNS of_IN excellence_NN that_WDT are_VBP run_VBN by_IN Africans_NNPS doing_VBG internationally_RB
        recognized_VBN research_NN that_WDT conforms_VBZ to_TO Good_NNP Clinical_NNP Practice_NNP guidelines_NNS ._. But_CC this_DT will_MD only_RB
        happen_VB if_IN African_JJ researchers_NNS are_VBP treated_VBN as_IN equal_JJ partners_NNS and_CC are_VBP allowed_VBN to_TO be_VB fully_RB
        engaged_VBN in_IN the_DT projects_NNS that_WDT are_VBP taking_VBG place_NN in_IN their_PRP$ countries_NNS ._.
        So_RB can_MD the_DT EDCTP_NNP work_NN ,_, or_CC is_VBZ it_PRP doomed_VBD to_TO failure_NN ?_. In_IN many_JJ ways_NNS the_DT organization_NN has_VBZ a_DT
        great_JJ deal_NN going_VBG for_IN it_PRP ._. Although_IN the_DT budget_NN of_IN 3400_CD million_CD spread_NN over_IN five_CD years_NNS is_VBZ tiny_JJ
        considering_VBG the_DT combined_VBN burden_NN of_IN HIV_NNP /_NN AIDS_NNP ,_, tuberculosis_NNS ,_, and_CC malaria_NN ,_, it_PRP is_VBZ important_JJ to_TO
        remember_VB that_IN it_PRP is_VBZ the_DT biggest_JJS single_JJ European_JJ project_NN for_IN clinical_JJ trials_NNS in_IN Africa_NNP ._. In_IN
        many_JJ ways_NNS the_DT EDCTP_NNP is_VBZ a_DT demonstration_NN project_NN :_: if_IN some_DT success_NN can_MD be_VB achieved_VBN it_PRP is_VBZ very_RB
        likely_JJ that_IN additional_JJ funds_NNS will_MD follow_VB ._. The_DT project_NN is_VBZ certainly_RB strengthened_VBN by_IN the_DT
        involvement_NN of_IN Pascoal_NNP Mocumbi_NNP ,_, the_DT former_JJ prime_JJ minister_NN of_IN Mozambique_NNP ,_, as_IN High_NNP
        Representative_NNP of_IN the_DT project_NN ._. Mocumbi_NNP is_VBZ highly_RB respected_VBN by_IN the_DT global-health_JJ community_NN
        and_CC carries_VBZ considerable_JJ weight_NN with_IN African_JJ politicians_NNS ._. Mobilization_NNP of_IN political_JJ will_MD
        within_IN Africa_NNP will_MD be_VB essential_JJ if_IN research_NN capacity_NN is_VBZ to_TO be_VB sustained_VBN for_IN the_DT long_JJ
        term_NN ._.
        On_IN the_DT downside_NN ,_, it_PRP seems_VBZ clear_JJ to_TO most_JJS insiders_NNS that_IN the_DT management_NN structure_NN needs_VBZ to_TO
        be_VB radically_RB changed_VBN and_CC partnership_NN with_IN other_JJ organizations_NNS needs_VBZ to_TO be_VB improved_VBN ._. The_DT
        EDCTP_NNP Assembly_NNP met_VBD on_IN October_NNP 28_CD and_CC 29_CD to_TO discuss_VB these_DT issues_NNS and_CC to_TO elect_VB a_DT new_JJ leader_NN ._.
        At_IN the_DT time_NN this_DT editorial_NN went_VBD to_TO press_VB ,_, there_EX was_VBD still_RB no_DT public_JJ announcement_NN of_IN the_DT
        outcome_NN of_IN this_DT meeting_NN ._. In_IN addition_NN ,_, the_DT political_JJ infighting_NN that_WDT pervades_NNS European_JJ
        politics_NNS at_IN all_DT levels_NNS needs_VBZ to_TO be_VB controlled_VBN ,_, or_CC at_IN least_RBS managed_VBN effectively_RB ._. This_DT might_MD
        be_VB a_DT tall_JJ order_NN ,_, but_CC it_PRP is_VBZ essential_JJ if_IN this_DT worthwhile_JJ and_CC high-profile_JJ project_NN is_VBZ to_TO
        succeed_VB ._.
      
    
  
